BR9814497A - Processo para prevenir ou retardar perda de campo visual associada com glaucoma ou hipertensão ocular - Google Patents
Processo para prevenir ou retardar perda de campo visual associada com glaucoma ou hipertensão ocularInfo
- Publication number
- BR9814497A BR9814497A BR9814497-9A BR9814497A BR9814497A BR 9814497 A BR9814497 A BR 9814497A BR 9814497 A BR9814497 A BR 9814497A BR 9814497 A BR9814497 A BR 9814497A
- Authority
- BR
- Brazil
- Prior art keywords
- prevent
- glaucoma
- visual field
- loss associated
- ocular hypertension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
"PROCESSO PARA PREVENIR OU RETARDAR PERDA DE CAMPO VISUAL ASSOCIADA COM GLAUCOMA OU HIPERTENSãO OCULAR, E, USO DE BRINZOLAMIDA NA FABRICAçãO DE UM MEDICAMENTO TóPICO" Processos para prevenir ou retardar perda visual são apresentados.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6876797P | 1997-12-23 | 1997-12-23 | |
PCT/US1998/023610 WO1999032123A1 (en) | 1997-12-23 | 1998-11-05 | The use of brinzolamide to prevent visual field loss |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9814497A true BR9814497A (pt) | 2000-10-10 |
Family
ID=22084577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9814497-9A BR9814497A (pt) | 1997-12-23 | 1998-11-05 | Processo para prevenir ou retardar perda de campo visual associada com glaucoma ou hipertensão ocular |
Country Status (12)
Country | Link |
---|---|
US (1) | US6242441B1 (pt) |
EP (1) | EP1047429A1 (pt) |
JP (1) | JP2001526231A (pt) |
KR (1) | KR20010015810A (pt) |
CN (1) | CN1178661C (pt) |
AR (1) | AR007230A1 (pt) |
AU (1) | AU750536B2 (pt) |
BR (1) | BR9814497A (pt) |
CA (1) | CA2310230C (pt) |
TW (1) | TWI241186B (pt) |
WO (1) | WO1999032123A1 (pt) |
ZA (1) | ZA9810837B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201210584A (en) | 2010-08-18 | 2012-03-16 | Alcon Res Ltd | Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5153192A (en) | 1990-04-09 | 1992-10-06 | Alcon Laboratories, Inc. | Thiophene sulfonamides useful as carbonic anhydrase inhibitors |
US5378703A (en) | 1990-04-09 | 1995-01-03 | Alcon Laboratories, Inc. | Sulfonamides useful as carbonic anhydrase inhibitors |
-
1998
- 1998-11-05 BR BR9814497-9A patent/BR9814497A/pt not_active Application Discontinuation
- 1998-11-05 EP EP98956622A patent/EP1047429A1/en not_active Ceased
- 1998-11-05 US US09/581,687 patent/US6242441B1/en not_active Expired - Lifetime
- 1998-11-05 JP JP2000525114A patent/JP2001526231A/ja active Pending
- 1998-11-05 AU AU13105/99A patent/AU750536B2/en not_active Ceased
- 1998-11-05 CN CNB988117452A patent/CN1178661C/zh not_active Expired - Fee Related
- 1998-11-05 KR KR1020007005125A patent/KR20010015810A/ko not_active Application Discontinuation
- 1998-11-05 CA CA002310230A patent/CA2310230C/en not_active Expired - Fee Related
- 1998-11-05 WO PCT/US1998/023610 patent/WO1999032123A1/en not_active Application Discontinuation
- 1998-11-26 ZA ZA9810837A patent/ZA9810837B/xx unknown
- 1998-12-01 TW TW087119893A patent/TWI241186B/zh not_active IP Right Cessation
- 1998-12-16 AR ARP980106403A patent/AR007230A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
TWI241186B (en) | 2005-10-11 |
JP2001526231A (ja) | 2001-12-18 |
CN1280496A (zh) | 2001-01-17 |
AR007230A1 (es) | 1999-10-27 |
CA2310230C (en) | 2008-05-06 |
AU750536B2 (en) | 2002-07-18 |
EP1047429A1 (en) | 2000-11-02 |
WO1999032123A1 (en) | 1999-07-01 |
ZA9810837B (en) | 1999-07-20 |
US6242441B1 (en) | 2001-06-05 |
KR20010015810A (ko) | 2001-02-26 |
CA2310230A1 (en) | 1999-07-01 |
CN1178661C (zh) | 2004-12-08 |
AU1310599A (en) | 1999-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2293657A1 (en) | Dual axis retroreflective articles | |
BR0015611A (pt) | Processo de limpeza que utiliza ondas ultra-sÈnicas | |
HUP0000944A2 (hu) | A 2-amino-4-(4-fluor-benzilamino)-1-etoxikarbonil-aminobenzol új módosulatai és eljárás előállításukra | |
BR9910251A (pt) | Estimulação hematopoiética | |
BR0009480A (pt) | Soluções de poliuretano com unidades de estrutura de alcoxissilano | |
DK0712426T3 (da) | Fluorescerende latex, som omfatter i det mindste to fluorokromer, fremgangsmåde til fremstilling deraf samt anvendelse deraf | |
BR9604878A (pt) | Preparado oftálmico em gel gotejável estéril e processo para sua preparação | |
BR9609297A (pt) | Processo para aumentar of fluxor sanguineo na retina | |
CA2251132A1 (en) | Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents | |
BR0016941A (pt) | Derivados de aminometil-fenil-ciclohexanona | |
BR9814497A (pt) | Processo para prevenir ou retardar perda de campo visual associada com glaucoma ou hipertensão ocular | |
WO1998031712A3 (en) | Chitosan-conjugates with acidic chelate-complex forming agents | |
FI973184A0 (fi) | Kombinaatioterapia HIV-infektiota varten käyttäen HIV-proteaasi-inhibiittoria indinavir ja käänteistranskriptaasi-inhibiittoria 3TC, mahdollisesti yhdessä AZT:n, DDI:n tai DDC:n kanssa | |
BR9814188A (pt) | "agonistas de 5-ht1f" | |
CA2316447A1 (en) | Rantes mutants and therapeutic applications thereof | |
BR9807785A (pt) | Processo para a preparação do composto, e, composto | |
PT1232173E (pt) | Derivados do acido fusidico | |
IT9048335A0 (it) | Composti con attivita' farmacologica antiipertensiva, analgesica, immunomodulante e antiinfiammatoria, che presentano nella molecola una sequenza di tre radicali, essendo alfa-amminoacido o quello centrale. | |
DK0865436T3 (da) | Dithiazoldioxider samt deres anvendelse som mikrobicider | |
BR9600773A (pt) | Benzenossulfonilurélas ou - tiourélas substituídas processo para sua preparação uso e medicamento | |
ES2150034T3 (es) | Empleo de las 2-aminotetralinas substituidas en 6,7 para la preparacion de composiciones farmaceuticas de utilidad para el tratamiento del choque septico, y composiciones farmaceuticas antipireticas y antiinflamatorias. | |
BR9607850A (pt) | Processo para a preparação de um composto e composto | |
CA2088370A1 (en) | New use of monoclonal antibody | |
TH26343EX (th) | แว่น | |
IT1280387B1 (it) | Uso di 2, 3-diidro-4(1h)-chinazolinoni e di composizioni farmaceutiche che li contengono nel trattamento dei disturbi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |